Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

41 results about "Acute upper respiratory tract infection" patented technology

Upper respiratory tract infections, are the illnesses caused by an acute infection which involves the upper respiratory tract: nose, sinuses, pharynx or larynx. An Upper Respiratory Infection (URI) is another name for the common cold. A cold is caused by a virus that can settle in your nose, throat or lungs.

Medicament for treating pediatric respiratory tract infection and pulmonary infection

The invention relates to a medicament for treating pediatric respiratory tract infection and pulmonary infection, which is prepared from campanumaea pilosula, giant knotweed, whiteflower hogfennel root, almond, pummelo peel, willowleaf swallowwort rhizome, indigowoad root, Ningpo yam rhizome, paniculate swallowwort root, Indian trum etflower seed, Chinese magnoliavine fruit, unibract fritillary bulb, pinellia tuber and the like. The medicament has the effects of resisting inflammation, resisting viruses, and relieving cough and asthma, and is used for treating diseases such as acute upper respiratory tract infection (cold and fever), pediatric pneumonia, bronchitis, chronic recurrent trachitis, pulmonary infection, whooping cough and the like. The medicament takes the giant knotweed and the indigowoad root for clearing heat and detoxicating, and cooling blood and disinhibiting throat, the whiteflower hogfennel root for dispelling wind heat of lungs, the almond, the pummelo peel, the willowleaf swallowwort rhizome, the pinellia tuber and the unibract fritillary bulb for eliminating phlegm and relieving cough, the paniculate swallowwort root, the Indian trum etflower seed and the Ningpo yam rhizome for clearing heat and disinhibiting dampness, resisting inflammation, relieving cough, resisting allergic reaction and resisting allergy, and the campanumaea pilosula for tonifying center vitality, strengthening spleen and tonifying lung, supporting right and expelling evil, relieving cough, improving immunity of patients, diffusing lung vitality and clearing phlegm and heat. Medicinal materials such as tatarian aster root and platycodon root are added into the medicament on the basis of the compatibility so as to add the effects of eliminating phlegm and preventing asthma.
Owner:张兆君

Chinese medicinal preparation for treating acute upper respiratory tract infection and preparation method thereof

The invention relates to a Chinese medicinal preparation for treating acute upper respiratory tract infection. The Chinese medicinal preparation is prepared from the following Chinese medicinal decoction pieces in part by weight: 6 to 14 parts of notopterygium root, 6 to 12 parts of mint, 8 to 12 parts of bupleurum falcatum, 9 to 12 parts of baikal skullcap root, 8 to 12 parts of sweet wormwood, 15 to 40 parts of gypsum, 12 to 18 parts of indigowoad leaves, 10 to 15 parts of common dayflower herb and 2 to 6 parts of raw liquorice. The processes of decocting, purifying, concentrating, drying and the like are determined according to the properties of different Chinese medicinal decoction pieces and properties of effective ingredients or parts; and the extraction rate and the content of baicalin are used as indexes, and the orthogonal test is adopted for determining. Volatile oils in the mint, the sweet wormwood and the notopterygium root are effective ingredients, and are extracted respectively and added when a solid preparation is formed finally. The preparation can be used for treating fever caused by acute upper respiratory tract infection, can effectively resist virus, brings down fever quickly, and improves pharyngalgia, cough and other upper respiratory clinical symptoms.
Owner:JIANGSU KANION PHARMA CO LTD

Preparation method of medicine for preventing and treating acute upper respiratory tract infection

The invention provides a preparation method of a medicine for preventing and treating acute upper respiratory tract infection. The medicine is prepared from the following raw materials in percentage by mass: 5 to 25 percent of fructus forsythiae, 8 to 25 percent of honeysuckle flower, 3 to 12 percent of field mint, 8 to 25 percent of great burdock fruit, 10 to 20 percent of balloon flower root, 6 to 15 percent of belamcandae root, 8 to 20 percent of isatis root, 8 to 20 percent of ledebouriella root, 8 to 20 percent of dryopteris root and 3 to 12 percent of licorice root. The raw medicines are extracted, concentrated, flocculated, clarified and then concentrated, and a preparation for preventing and treating acute upper respiratory tract infection is obtained under the condition of preserving the effect of raw medicines to a full extent. Proved by results of bacteriostatic tests on main pathogenic bacteria and pharmacology and toxicology tests on pain alleviation, inflammation resistance, and the like, the technology has the advantages of effectively enriching main active ingredients in raw medicines, reducing the losses of main active ingredients and improving antibacterial spectrum and bacteriostatic strength. The medicine effect, the safety and the reliability are better than those of a preparation made from the same raw materials with a traditional method. Meanwhile, preparation clarity can be improved, medicine occupation volume can be reduced, and the medicine is convenient to carry and convenient for children to take.
Owner:YUNNAN UNIV OF TRADITIONAL CHINESE MEDICINE

Traditional Chinese medicine preparation for treating acute upper respiratory tract infection and production method of traditional Chinese medicine preparation

The invention discloses a traditional Chinese medicine preparation for treating acute upper respiratory tract infection and a production method of the traditional Chinese medicine preparation, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine preparation consists of a honeysuckle flower extract, aqueous extracts of weeping forsythia capsule and baikal skullcap root, and beta cyclodextrin; and the traditional Chinese medicine preparation comprises the following components in parts by weight: 460-540 parts of honeysuckle flower, 460-540 parts of weeping forsythia capsule, 140-185 parts of baikal skullcap root and 30-80 parts of beta cyclodextrin. The traditional Chinese medicine preparation disclosed by the invention is high in medicine stability, less in auxiliary material dosage and wide in application range; by adopting the production method disclosed by the invention, effective components in each medicinal material in the preparation are subjected to distinguished treatment and are refined; and moreover, the production method is simple, has wide market prospects, and is suitable for large-scale production.
Owner:GUANGXI DOUBLE ANT PHARMA

Traditional Chinese medicine composition for treating acute upper respiratory tract infection in children and its preparation method and application

The invention provides a Chinese medicinal composition for treating child acute upper respiratory tract infection. The Chinese medicinal composition consists of the following medicines in part by weight: 10 to 90 parts of patchouli, 30 to 130 parts of indigowoad leaf, 30 to 130 parts of fermented soybean, 30 to 130 parts of officinal magnolia bark, 30 to 130 parts of pachyrhizua angulatus, 10 to 90 parts of Chinese mosla herb, 100 to 220 parts of gypsum, 5 to 50 parts of coptis chinensis, 30 to 130 parts of scutellaria baicalensis, 10 to 110 parts of talcpowder, 5 to 50 parts of liquorice, 30 to 130 parts of honeysuckle, 10 to 90 parts of processed rhizoma pinelliae, and pharmaceutical excipients. The invention also provides a preparation method for the Chinese medicinal composition for treating child acute upper respiratory tract infection. The invention has the advantages that: the Chinese medicinal composition overcomes the defects of conventional formulations such as decoction and the like; by an alcohol extraction method, fat soluble active ingredients which have clinical effects in the composition are kept; and by efficient, and dynamic circulatory extraction equipment, the active ingredients are extracted to the maximum extent, and the clinical effects are guaranteed, and the Chinese medicinal composition has a solid clinical basis and good clinical effects.
Owner:天津市石天药业有限责任公司

Qi-tonifying, dampness-eliminating and sore-throat-relieving dietary therapy formula and predation method and application thereof

The present invention belongs to the field of traditional Chinese medicines and particularly relates to a qi-tonifying, dampness-eliminating and sore-throat-relieving dietary therapy formula and a preparation method and an application thereof. The qi-tonifying, dampness-eliminating and sore-throat-relieving dietary therapy formula comprises the following food materials in parts by weight: 6-15 parts of sun-dried ginseng or American ginseng, 1-6 parts of dried orange peel, 1-3 parts of Chinese olives, 3-15 parts of fresh ginger and 250-500 parts of lean meat. The present invention also providesthe preparation method and the application of the qi-tonifying, dampness-eliminating and sore-throat-relieving dietary therapy formula. The dietary therapy formula is suitable for asymptomatic patients with novel coronavirus infection, people with mild symptoms of weakness of the spleen and the stomach, short breath and hypodynamia after activities, qi deficiency and lassitude, thirst and dry throat, dry tongue and little body fluid, dry stool or little qi and vain straining, and people with mild symptoms of weakness, chronic pharyngitis, cough, throat itching, dry throat, pharyngalgia, hoarseness and hypodynamia. Meanwhile, the dietary therapy formula also has effects of relieving symptoms such as fever, cough, dry throat, throat itching, sore throat, hoarseness, hypodynamia and the likecaused by influenza and acute upper respiratory tract infection (such as common cold, viral pharyngitis, laryngitis, herpangina and the like).
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Chinese medicinal preparation for treating acute upper respiratory tract infection and preparation method thereof

The invention relates to a Chinese medicinal preparation for treating acute upper respiratory tract infection. The Chinese medicinal preparation is prepared from the following Chinese medicinal decoction pieces in part by weight: 6 to 14 parts of notopterygium root, 6 to 12 parts of mint, 8 to 12 parts of bupleurum falcatum, 9 to 12 parts of baikal skullcap root, 8 to 12 parts of sweet wormwood, 15 to 40 parts of gypsum, 12 to 18 parts of indigowoad leaves, 10 to 15 parts of common dayflower herb and 2 to 6 parts of raw liquorice. The processes of decocting, purifying, concentrating, drying and the like are determined according to the properties of different Chinese medicinal decoction pieces and properties of effective ingredients or parts; and the extraction rate and the content of baicalin are used as indexes, and the orthogonal test is adopted for determining. Volatile oils in the mint, the sweet wormwood and the notopterygium root are effective ingredients, and are extracted respectively and added when a solid preparation is formed finally. The preparation can be used for treating fever caused by acute upper respiratory tract infection, can effectively resist virus, brings down fever quickly, and improves pharyngalgia, cough and other upper respiratory clinical symptoms.
Owner:JIANGSU KANION PHARMA CO LTD

Chinese medicinal composition for treating child acute upper respiratory tract infection, and preparation method and application thereof

The invention provides a Chinese medicinal composition for treating child acute upper respiratory tract infection. The Chinese medicinal composition consists of the following medicines in part by weight: 10 to 90 parts of patchouli, 30 to 130 parts of indigowoad leaf, 30 to 130 parts of fermented soybean, 30 to 130 parts of officinal magnolia bark, 30 to 130 parts of pachyrhizua angulatus, 10 to 90 parts of Chinese mosla herb, 100 to 220 parts of gypsum, 5 to 50 parts of coptis chinensis, 30 to 130 parts of scutellaria baicalensis, 10 to 110 parts of talcpowder, 5 to 50 parts of liquorice, 30 to 130 parts of honeysuckle, 10 to 90 parts of processed rhizoma pinelliae, and pharmaceutical excipients. The invention also provides a preparation method for the Chinese medicinal composition for treating child acute upper respiratory tract infection. The invention has the advantages that: the Chinese medicinal composition overcomes the defects of conventional formulations such as decoction and the like; by an alcohol extraction method, fat soluble active ingredients which have clinical effects in the composition are kept; and by efficient, and dynamic circulatory extraction equipment, the active ingredients are extracted to the maximum extent, and the clinical effects are guaranteed, and the Chinese medicinal composition has a solid clinical basis and good clinical effects.
Owner:天津市石天药业有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products